VIP

Research Phase

Vasoactive Intestinal Peptide

Aliases
Vasoactive Intestinal Polypeptide, Aviptadil
Administration
Intravenous infusion (studied), Subcutaneous injection (research)

Research and regulatory

Development stage

Naturally occurring peptide studied across gut, immune, and respiratory research; a synthetic form (Aviptadil) has been studied in clinical trials for several conditions.

Legal and regulatory

Naturally occurring in the body; synthetic pharmaceutical forms are investigational and not broadly FDA approved.

Side effects

Flushing, GI effects, injection site reactions